Aton acquires U.S. marketing rights for timolol - - Ophthalmology Times
Links shared publicly online about this topic.
- 2,208total visits
Aton acquires U.S. marketing rights for timolol - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com —
Aton Pharma Inc. has acquired the U.S. marketing rights to the timolol (Timoptic) product line from Merck & Co. Inc.
View full resource at ophthalmologytimes.modernmedicine.com
Tags: Migraine Prevention Medication, Glaucoma Medication, Intraocular Pressure Medication, Pharma, Timoptic, Betimol, Istalol, Ophthalmology
Most Recently Shared on March 7, 2009 at 12:15 pm By:
Aton acquires U.S. marketing rights for timolol. http://ow.ly/Gde
Advertisement
